awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33639041-2D94455B-5CFD-49ED-853C-9EE164054745
Q33639041-2D94455B-5CFD-49ED-853C-9EE164054745
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33639041-2D94455B-5CFD-49ED-853C-9EE164054745
Efficacy and Safety of Fingolimod in Daily Practice: Experience of an Academic MS French Center
P2860
Q33639041-2D94455B-5CFD-49ED-853C-9EE164054745
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33639041-2D94455B-5CFD-49ED-853C-9EE164054745
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
16ab57c3e1e2fbf30b16230066d8acf2b9d9b20f
P2860
Are natalizumab and fingolimod analogous second-line options for the treatment of relapsing-remitting multiple sclerosis? A clinical practice observational study.